Department of Forensic Sciences, Oslo University Hospital, Nydalen, Oslo, Norway; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Forensic Sciences, Oslo University Hospital, Nydalen, Oslo, Norway; Norwegian Centre for Addiction Research, University of Oslo, Blindern, Oslo, Norway.
Drug Alcohol Depend. 2019 Nov 1;204:107588. doi: 10.1016/j.drugalcdep.2019.107588. Epub 2019 Sep 25.
The aim was to estimate the prevalence of harmful alcohol use in relation to socio-demographic characteristics among acutely ill medical patients, and examine identification measures of alcohol use, including the alcohol biomarker phosphatidylethanol 16:0/18:1 (PEth).
A cross-sectional study, lasting one year at one hospital in Oslo, Norway and one in Moscow, Russia recruiting acute medically ill patients (≥ 18 years), able to give informed consent. Self-reported data on socio-demographics, mental distress (Symptom Check List-5), alcohol use (Alcohol Use Disorder Identification Test-4 (AUDIT-4) and alcohol consumption past 24 h were collected. PEth and alcohol concentration were measured in whole blood.
Of 5883 participating patients, 19.2% in Moscow and 21.1% in Oslo were harmful alcohol users, measured by AUDIT-4, while the prevalence of PEth-positive patients was lower: 11.4% in Oslo, 14.3% in Moscow. Men in Moscow were more likely to be harmful users by AUDIT-4 and PEth compared to men in Oslo, except of those being ≥ 71 years. Women in Oslo were more likely to be harmful users compared to those in Moscow by AUDIT-4, but not by PEth for those aged < 61 years.
The prevalence of harmful alcohol use was high at both study sites. The prevalence of harmful alcohol use was lower when assessed by PEth compared to AUDIT-4. Thus, self-reporting was the most sensitive measure in revealing harmful alcohol use among all groups except for women in Moscow. Hence, screening and identification with objective biomarkers and self-reporting might be a method for early intervention.
本研究旨在评估急性病医疗患者中与社会人口学特征相关的有害饮酒流行率,并检验酒精使用的识别措施,包括酒精生物标志物 16:0/18:1 磷脂酰乙醇(PEth)。
本研究为一项在挪威奥斯陆和俄罗斯莫斯科各一家医院进行的横断面研究,持续一年,招募了能够知情同意的急性病成年患者。收集了自我报告的社会人口统计学、精神困扰(症状清单 5)、酒精使用(酒精使用障碍识别测试 4(AUDIT-4)和过去 24 小时的酒精摄入量)数据。采集全血以测量 PEth 和酒精浓度。
在 5883 名参与研究的患者中,莫斯科和奥斯陆的有害饮酒者分别占 19.2%和 21.1%,由 AUDIT-4 测量;而 PEth 阳性患者的比例较低:奥斯陆为 11.4%,莫斯科为 14.3%。莫斯科的男性比奥斯陆的男性更有可能通过 AUDIT-4 和 PEth 成为有害使用者,除了那些年龄≥71 岁的患者。奥斯陆的女性比莫斯科的女性更有可能通过 AUDIT-4 成为有害使用者,但对于年龄<61 岁的患者,并非通过 PEth。
两个研究地点的有害饮酒流行率均较高。与 AUDIT-4 相比,PEth 评估的有害饮酒流行率较低。因此,除了莫斯科的女性外,自我报告是揭示所有人群中有害饮酒的最敏感措施。因此,使用客观的生物标志物和自我报告进行筛查和识别可能是早期干预的一种方法。